Q3 2013 Holdings
Filed 2013-11-14 | 107 holdings | $22.8M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2013-11-14) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $16.8M | 610,615 | 73.5% |
| Anika Therapeutics Inc(ANIK) | COM | 035255108 | $3.4M | 144,067 | 15.1% |
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $1.4M | 190,588 | 6.1% |
| Aegerion Pharmaceuticals Inc | COM | 00767E102 | $199.7K | 2,328,341 | 0.9% |
| Sarepta Therapeutics Inc(SRPT)A | COM | 803607100 | $130.9K | 2,772,069 | 0.6% |
| Onyx Pharmaceuticals Inc | COM | 683399109 | $69.5K | 556,944 | 0.3% |
| Acelrx Pharmaceuticals Inc(ACRXUSD) | COM | 00444T100 | $63.2K | 5,858,400 | 0.3% |
| Tesaro Inc | COM | 881569107 | $58.6K | 1,513,644 | 0.3% |
| Celgene Corp(CELG) | COM | 151020104 | $56.2K | 364,619 | 0.2% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $54.3K | 864,070 | 0.2% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $48.3K | 4,270,704 | 0.2% |
| Repros Therapeutics Inc | COM NEW | 76028H209 | $39.7K | 1,481,733 | 0.2% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $34.3K | 452,095 | 0.2% |
| Ishares(IBB)Put | NASDQ BIOTEC ETF | 464287556 | $30.4K | 144,800 | 0.1% |
| Questcor Pharmaceuticals Inc | COM | 74835Y101 | $21.8K | 376,350 | 0.1% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $20.6K | 1,748,314 | 0.1% |
| Axogen Inc(AXGN) | COM | 05463X106 | $20.0K | 4,500 | 0.1% |
| Mylan Inc | COM | 628530107 | $17.6K | 460,305 | 0.1% |
| Cigna Corporation | COM | 125509109 | $17.1K | 222,848 | 0.1% |
| Neptune Technologies Bioreso | COM | 64077P108 | $17.1K | 5,383,857 | 0.1% |
| Synta Pharmaceuticals Corp | COM | 87162T206 | $15.0K | 2,381,236 | 0.1% |
| Health NET Inc | COM | 42222G108 | $14.4K | 453,780 | 0.1% |
| Arena Pharmaceuticals IncPut | COM | 040047102 | $13.5K | 2,558,100 | 0.1% |
| Pacira Pharmaceuticals Inc(PCRX) | COM | 695127100 | $13.1K | 272,034 | 0.1% |
| Capital SR Living Corp | COM | 140475104 | $13.0K | 614,089 | 0.1% |
| Covidien PLC | SHS | G2554F113 | $12.9K | 211,245 | 0.1% |
| Santarus Inc | COM | 802817304 | $12.0K | 532,243 | 0.1% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $11.8K | 194,701 | 0.1% |
| Dyax Corp | COM | 26746E103 | $11.6K | 1,692,912 | 0.1% |
| Cell Therapeutics Inc | COM NPV NEW 2012 | 150934883 | $11.3K | 6,994,673 | 0.0% |
| Anacor Pharmaceuticals Inc | COM | 032420101 | $10.3K | 973,868 | 0.0% |
| Ishares(IWM)Put | RUSSELL 2000 ETF | 464287655 | $10.3K | 96,500 | 0.0% |
| Amgen Inc(AMGN) | COM | 031162100 | $10.3K | 91,675 | 0.0% |
| Chelsea Therapeutics Intl LT | COM | 163428105 | $10.2K | 3,418,365 | 0.0% |
| Sangamo Biosciences Inc(SGMO) | COM | 800677106 | $10.1K | 965,000 | 0.0% |
| Walgreen Co | COM | 931422109 | $10.1K | 187,870 | 0.0% |
| NPS Pharmaceuticals Inc | COM | 62936P103 | $9.7K | 305,762 | 0.0% |
| Vanda Pharmaceuticals Inc(VNDA) | COM | 921659108 | $9.5K | 868,500 | 0.0% |
| Wellcare Health Plans Inc | COM | 94946T106 | $9.2K | 132,081 | 0.0% |
| Isis Pharmaceuticals Inc | COM | 464330109 | $7.2K | 192,800 | 0.0% |
| Endocyte Inc | COM | 29269A102 | $5.6K | 418,715 | 0.0% |
| Amarin Corp PLCPut | SPONS ADR NEW | 023111206 | $5.5K | 868,500 | 0.0% |
| Vanda Pharmaceuticals Inc(VNDA)Call | COM | 921659108 | $5.3K | 482,600 | 0.0% |
| Repros Therapeutics IncCall | COM NEW | 76028H209 | $5.2K | 193,000 | 0.0% |
| Intermune Inc | COM | 45884X103 | $4.6K | 300,000 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $4.6K | 737,505 | 0.0% |
| Stemline Therapeutics Inc | COM | 85858C107 | $4.1K | 90,208 | 0.0% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $3.6K | 572,870 | 0.0% |
| Athersys Inc(ATHXEUR) | COM | 04744L106 | $3.5K | 2,150,117 | 0.0% |
| Coronado Biosciences IncPut | COM | 21976U109 | $3.5K | 501,900 | 0.0% |